{"database": "openregs", "table": "dockets", "rows": [["FDA-2003-P-0007", "FDA", "determine whether Lexapro (escitalopram oxalate) tablets 5 mg (NDA 21-323, Product 001),manufactured by Forest laboratories, have been withdrawn or withheld from sale for safety or efficacy reasons", "Nonrulemaking", "2021-09-01T01:02:52Z", "0b000064804811ab"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-P-0007"], "units": {}, "query_ms": 21.673385053873062, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}